Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Elevated Serum TFF3 Levels in Gastric Cancer Patients Linked to Hepatic Source

  • By

  • Komei Kuge

  • Junko Mukohyama

  • Yoshimi Yasukawa

  • Yuko Ishibashi

  • Hiroki Masuda

  • Tomohiko Yasuda

  • Yasukazu Ohmoto

  • Hideyuki Takeshima

  • Akihisa Matsuda

  • Hiroshi Yoshida

  • Yasuyuki Seto

  • James R. Goldenring

  • Toshikazu Ushijima

  • Sachiyo Nomura

  • August 25, 2026

Share

Original Source(s)

Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

  • by Komei Kuge, Junko Mukohyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura

  • August 25, 2026

Related Content

Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML

New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a difficult-to-treat form of acute myeloid leukemia (AML).

  • by

  • August 26, 2026

  • 3 min
Implementation Strategies in Cascade Genetic Testing—The Devil Is in the Details

Error in the Byline

  • August 27, 2026